What Researchers Did
The researchers looked back at the records of 42 patients with a severe, fast-spreading soft tissue infection called necrotizing fasciitis, who were treated with hyperbaric oxygen therapy (HBO2) added to surgery, antibiotics and intensive care.
What They Found
This retrospective study of 42 patients with necrotizing fasciitis treated with adjunctive HBO2 found a mortality of 11.9% (5 patients) and no amputations after arrival at the treating center. Two amputations (a finger and a penis) happened before patients were transported there. Patients had an average of 2.8 surgical debridements, 1.25 of them before HBO2 started, and the infection was controlled after an average of 7 HBO2 treatments. Mild ear barotrauma occurred in 3 patients (7%) and confinement anxiety in 17 (41%), but neither prevented treatment.
What This Means for Canadian Patients
For people with necrotizing fasciitis, this abstract describes outcomes in one group who received HBO2 alongside surgery, antibiotics and critical care. The authors compared their results with national reports and saw lower mortality and fewer amputations, but the study had no control group and the abstract reports no statistical test of that comparison. It also reports that HBO2 did not delay surgery or interfere with standard treatment. Ear pressure injury and anxiety about being enclosed in the chamber were the side effects reported.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a retrospective review of 42 patients at one referral center with no control group, so it cannot show that HBO2 caused the lower mortality and amputation rates, and the comparison with national reports (34% versus 11.9% mortality) was not backed by a statistical test in the abstract.